Phototherapy Equipment Market Size, Growth and Forecast 2032

Market Overview:

The Phototherapy Equipment Market size was valued at USD 385.8 million in 2018 to USD 486.7 million in 2024 and is anticipated to reach USD 670.3 million by 2032, at a CAGR of 4.10% during the forecast period.

One of the major drivers accelerating the phototherapy equipment market is the growing prevalence of dermatological disorders and neonatal jaundice. Conditions such as psoriasis, vitiligo, acne, and atopic dermatitis continue to rise across all age groups, creating strong clinical demand for safe, light-based therapies. Neonatal jaundice, affecting a significant proportion of newborns, particularly in developing nations, further reinforces the need for phototherapy devices in maternity wards and pediatric ICUs. The continuous evolution of technology-especially the shift from conventional fluorescent to energy-efficient LED phototherapy units-has improved treatment outcomes and extended product lifespans. Furthermore, the rise in demand for portable, home-based devices supports outpatient and homecare treatment models, boosting overall device adoption. Increasing patient awareness regarding the safety, non-invasiveness, and affordability of phototherapy solutions also plays a key role in driving market penetration across varied healthcare settings.

Regionally, North America dominates the phototherapy equipment market. This leadership is underpinned by a high prevalence of skin diseases, advanced healthcare systems, widespread insurance coverage, and rapid uptake of smart phototherapy technologies, particularly in the U.S. Europe follows closely, benefiting from mature regulatory frameworks, established dermatology care networks, and consistent investment in hospital infrastructure. Meanwhile, Asia-Pacific emerges as the fastest-growing region, with countries such as China and India experiencing a rise in neonatal jaundice cases and increasing healthcare access. Expanding hospital networks, public health initiatives, and growing awareness of phototherapy benefits are enhancing market prospects in this region. Latin America and the Middle East & Africa are still in the early stages of market development but show considerable growth potential due to healthcare modernization and expanding medical device distribution networks. These regional dynamics collectively indicate a shift toward broader global adoption of phototherapy technologies.

Market Insights:

• The Phototherapy Equipment Market was valued at USD 486.7 million in 2024 and is expected to reach USD 670.3 million by 2032, growing at a CAGR of 4.10%.
• Rising incidences of neonatal jaundice globally, especially in low- and middle-income countries, are fueling demand for advanced phototherapy systems in maternity wards and NICUs.
• Increasing cases of skin disorders like psoriasis, vitiligo, eczema, and acne are creating strong clinical need for safe, light-based therapies across all age groups.
• LED-based phototherapy units are replacing conventional systems, offering longer life, energy efficiency, and smart features such as automated light adjustment and treatment tracking.
• Portable and user-friendly devices are driving the shift toward home-based and outpatient phototherapy, aligning with the rise of decentralized and patient-centric care.
• Challenges such as high equipment costs and limited reimbursement restrict market access in underserved regions, slowing growth in some developing economies.
• North America leads the global market due to robust infrastructure and rapid technology adoption, while Asia-Pacific remains the fastest-growing region supported by rising healthcare investments.

Market Drivers:

Rising Incidence of Neonatal Jaundice Across Developing and Developed Nations

The increasing prevalence of neonatal jaundice is one of the primary factors propelling demand in the Phototherapy Equipment Market. Newborn jaundice affects over 60% of term infants and nearly 80% of preterm infants worldwide, requiring immediate and effective treatment to prevent severe neurological damage. Phototherapy remains the gold standard in managing hyperbilirubinemia, driving hospitals and neonatal intensive care units (NICUs) to invest in advanced devices. The demand is especially pronounced in low- and middle-income countries where birth rates remain high, and access to early diagnostic tools is expanding. Public health campaigns focusing on neonatal care have increased awareness, prompting early detection and timely treatment. As neonatal healthcare infrastructure improves, it creates sustained market growth across emerging regions.

Growing Burden of Dermatological Conditions Requiring Non-Invasive Light Therapy

The global rise in skin-related disorders such as psoriasis, vitiligo, eczema, and acne has significantly influenced the expansion of the Phototherapy Equipment Market. These chronic conditions often require long-term therapy, and phototherapy offers an effective, drug-free alternative that reduces side effects associated with systemic medications. It provides relief by using targeted ultraviolet light to slow abnormal skin cell growth and alleviate inflammation. This treatment approach appeals to patients and physicians looking for safe and repeatable solutions without the risks of long-term pharmacological interventions. With the increasing incidence of autoimmune and inflammatory skin diseases, dermatology clinics and hospitals are expanding their phototherapy portfolios. The market benefits from rising patient preference for non-invasive therapies with minimal downtime.

• For example, Philips BlueControlis a wearable, UV-free blue LED light therapy device for mild to moderate plaque psoriasis. It is clinically proven to reduce plaque symptoms and allows patients to treat affected areas conveniently at home. The device has been approved for use in Europe and the U.S., with studies confirming significant improvement in the Local Psoriasis Severity Index for treated individuals.

Technological Advancements in LED Phototherapy Devices and Smart Monitoring Systems

Rapid technological innovation has elevated the performance and accessibility of modern phototherapy equipment. LED-based devices now offer higher irradiance, lower power consumption, longer lifespan, and better portability compared to traditional fluorescent systems. These enhancements support broader clinical applications and reduce operational costs for healthcare providers. Some systems integrate smart monitoring tools that automatically adjust light intensity based on patient response and treatment duration, improving safety and treatment precision. The Phototherapy Equipment Market is benefitting from the miniaturization and digitalization of components, which enable manufacturers to create compact, user-friendly models for both hospital and home settings. The trend toward smart, connected devices aligns with global healthcare digitization efforts.

• For instance, Phoenix Medical Systems’ Brilliance Prois an LED-based phototherapy device for neonatal jaundice that features integrated light meters for real-time irradiance measurement and meets AAP standards for effective therapy. The device offers a long LED lifespan (over 120,000 hours) and includes machine and therapy time totalizers for precise monitoring, supporting both safety and efficiency in clinical settings.

Expansion of Home-Based Care and Outpatient Treatment Models

Changing healthcare preferences have led to a growing shift toward home-based care and outpatient services. Patients managing chronic skin conditions or mild neonatal jaundice often prefer the comfort and convenience of at-home phototherapy units. Manufacturers are responding by introducing portable, easy-to-operate equipment suitable for non-clinical settings. These devices allow patients to adhere to treatment schedules without frequent hospital visits, improving outcomes and reducing system burdens. It reflects a broader healthcare trend favoring patient-centric care and decentralized treatment delivery. The Phototherapy Equipment Market is gaining momentum from this transition, particularly in high-income regions with well-established telehealth and homecare frameworks.

Market Trends:

Integration of Artificial Intelligence and IoT for Personalized Phototherapy

The adoption of artificial intelligence (AI) and Internet of Things (IoT) in phototherapy devices is reshaping the market landscape. AI-driven systems can analyze patient data in real time to personalize treatment duration, dosage, and intensity, enhancing therapeutic outcomes. IoT integration enables remote monitoring and data sharing with healthcare providers, promoting consistent follow-up and compliance. These innovations reduce human error and optimize clinical workflows, especially in busy dermatology or neonatal units. The Phototherapy Equipment Market is beginning to incorporate these digital capabilities into mainstream offerings, aligning with global trends in smart healthcare. Hospitals and home users are increasingly investing in these intelligent systems due to their efficiency and patient-centric design.

• For example, Daavlin’s home-based narrowband UV-B phototherapy units, such as the Daavlin 7 Series, utilize a dosimetry-based controller called Guided Mode. This system tailors the initial and subsequent light doses according to the patient’s Fitzpatrick skin type, dermatologist-defined protocol, and real-time feedback on skin response.

Development of Hybrid Devices Combining Multiple Light Therapies

Manufacturers are designing hybrid phototherapy equipment that can deliver multiple wavelengths or combine ultraviolet and visible light therapies. These systems cater to diverse treatment protocols, offering flexibility for clinicians managing complex conditions like combined psoriasis and acne. Hybrid devices improve space efficiency and clinical versatility, making them attractive to both large hospitals and small dermatology practices. It enables a single system to treat a wide spectrum of conditions, reducing capital expenditure and improving return on investment. The Phototherapy Equipment Market is witnessing a shift toward multifunctional platforms that offer tailored treatment through adjustable light settings. This trend supports increased market adoption across outpatient and specialized care environments.

• The Dermalux Flex MD, for instance, is a medically CE-certified and FDA-approved device that uses Tri-Wave MD ceramic LED technology to emit blue (415nm), red (633nm), and near-infrared (830nm) light. This device offers seven single and multi-wavelength treatment modes, a dose range of 10 to 40 joules, and intensity settings from 5 to 27 mW/cm².

Increased Focus on Aesthetic and Cosmetic Dermatology Applications

Beyond medical dermatology, phototherapy is gaining traction in aesthetic and cosmetic treatments. Clinics and medspas are using light-based therapies for anti-aging, hyperpigmentation, and acne scar reduction, expanding the customer base for manufacturers. Consumers seek non-invasive and pain-free cosmetic solutions, and light therapy meets this demand with minimal recovery time. Equipment used in aesthetic care often includes features like color LED therapy and adjustable intensity to suit various skin types. The Phototherapy Equipment Market is expanding into this segment through devices designed for both clinical and personal use. The intersection of wellness, beauty, and light-based technology is opening new revenue streams for industry players.

Surge in Demand for Compact and Travel-Friendly Devices for Personal Use

Consumers are increasingly interested in portable and travel-friendly phototherapy equipment for personal skincare and newborn care needs. These devices cater to on-the-go users, particularly in urban markets where convenience drives product selection. Compact designs and rechargeable power sources make home phototherapy viable for people with busy lifestyles or limited access to clinical care. Manufacturers are responding by producing foldable units and handheld wands that fit into routine wellness regimens. The Phototherapy Equipment Market is evolving to serve this mobility-conscious demographic, offering professional-grade results in user-friendly formats. This shift supports market diversification and deeper penetration into the consumer health segment.

Market Challenges Analysis:

High Equipment Costs and Limited Accessibility in Low-Income Regions

The high upfront cost of phototherapy equipment continues to restrict its accessibility, particularly in low- and middle-income countries. Hospitals and clinics in these regions often lack the capital to invest in advanced devices, especially those equipped with LED or smart technologies. This financial barrier limits the adoption of effective phototherapy solutions, leaving many patients without timely treatment. The Phototherapy Equipment Market faces constraints in scaling operations where healthcare infrastructure remains underdeveloped. Limited reimbursement policies and scarce funding for neonatal and dermatological care further exacerbate the issue. Efforts to introduce low-cost, durable devices have begun but remain insufficient to bridge the access gap in underserved markets.

Lack of Skilled Technicians and Operational Challenges in Clinical Settings

Phototherapy devices require precise calibration and monitoring to deliver effective treatment, yet many facilities struggle with a shortage of trained professionals. Clinicians and technicians must be well-versed in treatment protocols, light dosimetry, and equipment maintenance to ensure safety and efficacy. Inadequate training often leads to inconsistent outcomes, user errors, or equipment misuse, affecting patient confidence. The Phototherapy Equipment Market must contend with varying levels of healthcare workforce preparedness, especially in rural or resource-limited settings. Operational challenges also include power supply limitations, maintenance costs, and inadequate after-sales support. These issues hinder long-term equipment functionality and reduce return on investment for healthcare providers.

Market Opportunities:

Emergence of Telemedicine and Remote Phototherapy Solutions

The growing adoption of telemedicine presents a significant opportunity for expanding phototherapy access beyond traditional clinical settings. Patients managing chronic skin conditions or mild neonatal jaundice increasingly prefer home-based treatments under virtual medical supervision. Manufacturers can capitalize on this trend by developing compact, connected phototherapy units integrated with remote monitoring features. It allows dermatologists and pediatricians to track treatment progress and make timely adjustments without in-person visits. The Phototherapy Equipment Market can leverage this model to increase device adoption in remote and underserved areas. The alignment of phototherapy with virtual care platforms supports broader healthcare decentralization.

Untapped Potential in Emerging Economies with Expanding Healthcare Infrastructure

Emerging economies offer promising growth avenues due to rising healthcare investment and improving public health programs. Governments in Asia, Africa, and Latin America are strengthening neonatal care and dermatology services, creating demand for affordable and effective treatment options. Local manufacturing partnerships and public-private initiatives can reduce cost barriers and improve distribution. It enables companies to establish early footholds in high-growth regions with large patient populations. The Phototherapy Equipment Market stands to gain from this momentum, especially by offering durable, user-friendly, and energy-efficient systems. Strategic localization and awareness campaigns can further accelerate market penetration in these regions.

Market Segmentation Analysis:

The Phototherapy Equipment Market is segmented by type, application, and end user, each contributing distinctly to its overall growth.

By type, LED-based phototherapy equipment dominates the market due to its energy efficiency, compact size, and longer lifespan. Fiberoptic phototherapy devices are primarily used for neonatal care, offering flexibility and localized treatment, while conventional equipment with fluorescent lamps is declining due to higher energy use and limited durability.

• For example, the GE Healthcare BiliSoft 2.0 Phototherapy System is a fiberoptic device specifically engineered for neonatal jaundice management. It features a flexible fiberoptic pad that delivers high-intensity blue light (peak wavelength ~450nm) directly to the infant’s skin, allowing for effective, localized treatment while enabling parent-infant bonding during therapy.

By application, the market is led by skin disease treatment, with growing demand for therapies addressing psoriasis, vitiligo, eczema, and other chronic conditions. Psoriasis and vitiligo remain major segments due to their rising global prevalence and demand for long-term, non-invasive solutions. Neonatal jaundice management continues to hold a significant share, especially in developing regions with high birth rates.

By end user, hospitals and clinics represent the largest share due to high patient inflow, advanced infrastructure, and broader treatment capabilities. It is followed by home users, a rapidly growing segment driven by increased availability of portable, user-friendly devices and a shift toward self-managed care in chronic dermatological conditions.

• For instance, the Solarc Home UVB Phototherapy System is an FDA-registered device designed for patient-administered phototherapy at home. It is compact, easy to operate, and includes safety features such as dose tracking and automatic shut-off. The system supports the growing trend of self-managed care for chronic skin conditions, with documented effectiveness comparable to clinical treatment when used under physician guidance.

Segmentation:

By Type

• LED-Based Phototherapy Equipment
• Fiberoptic Phototherapy Equipment
• Conventional Phototherapy Equipment with Fluorescent Lamps

By Application

• Skin Disease Treatment
  • Psoriasis
  • Vitiligo
  • Eczema/Atopic Dermatitis
  • Others
• Neonatal Jaundice Management

By End User

• Hospitals & Clinics
• Home Users

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Regional Analysis:

The North America Phototherapy Equipment Market size was valued at USD 87.88 million in 2018 to USD 107.16 million in 2024 and is anticipated to reach USD 140.76 million by 2032, at a CAGR of 3.5% during the forecast period. North America holds a dominant position in the global Phototherapy Equipment Market with a market share of 21%. The region benefits from advanced healthcare infrastructure, high awareness of neonatal and dermatological treatments, and widespread access to insurance reimbursement. The United States leads in both device innovation and clinical adoption, supported by strong research and development pipelines. Hospitals and outpatient centers are rapidly integrating LED-based and smart phototherapy systems into standard care protocols. It continues to benefit from government funding, academic partnerships, and increased investment in home-based healthcare technologies. Growth is further reinforced by rising demand for aesthetic phototherapy procedures among aging and beauty-conscious populations.

The Europe Phototherapy Equipment Market size was valued at USD 95.60 million in 2018 to USD 116.44 million in 2024 and is anticipated to reach USD 152.69 million by 2032, at a CAGR of 3.5% during the forecast period. Europe accounts for 23% of the global market share, driven by strong public healthcare systems and standardized treatment protocols for dermatology and neonatal care. Countries such as Germany, France, and the U.K. have well-established clinical pathways and reimbursement frameworks that support phototherapy use. The market benefits from the presence of major equipment manufacturers and regulatory harmonization across EU member states. It is witnessing a shift toward portable and hybrid devices, especially for use in ambulatory and home settings. The adoption of phototherapy for both therapeutic and cosmetic applications is rising steadily. Demand is particularly high in urban centers with concentrated specialist clinics.

The Asia Pacific Phototherapy Equipment Market size was valued at USD 120.02 million in 2018 to USD 161.62 million in 2024 and is anticipated to reach USD 241.30 million by 2032, at a CAGR of 5.1% during the forecast period. Asia Pacific represents the largest regional share at 35%, driven by high birth rates, growing incidences of neonatal jaundice, and increased investments in healthcare infrastructure. China, India, and Japan are key contributors to regional growth, with rapid expansion of neonatal care units and dermatology centers. The Phototherapy Equipment Market in Asia Pacific is seeing heightened demand for affordable, portable devices, particularly in rural and semi-urban areas. Governments are implementing public health programs and subsidies to improve access to newborn care. It is also experiencing growing consumer interest in light-based aesthetic therapies. Local manufacturing and favorable import policies are improving equipment availability across the region.

The Latin America Phototherapy Equipment Market size was valued at USD 40.32 million in 2018 to USD 49.46 million in 2024 and is anticipated to reach USD 65.55 million by 2032, at a CAGR of 3.6% during the forecast period. Latin America holds 11% of the global market share, supported by increasing awareness of neonatal health and growing access to public healthcare. Brazil, Mexico, and Argentina are leading markets with expanding pediatric care infrastructure and rising demand for phototherapy in dermatological clinics. It benefits from international collaborations and donor-funded healthcare initiatives aimed at improving infant care standards. The market is gradually adopting advanced devices, although cost constraints still limit access in low-income populations. Urban hospitals are incorporating hybrid and LED systems into treatment programs. Growth opportunities exist in expanding mobile healthcare delivery models across underserved regions.

The Middle East Phototherapy Equipment Market size was valued at USD 27.43 million in 2018 to USD 35.54 million in 2024 and is anticipated to reach USD 50.67 million by 2032, at a CAGR of 4.5% during the forecast period. The Middle East contributes 8% to the global market, with steady growth supported by modernization of healthcare facilities and investment in neonatal intensive care units. Countries like the UAE and Saudi Arabia are leading regional adopters, driven by national health strategies and increasing private sector participation. The Phototherapy Equipment Market in this region benefits from partnerships with international medical device suppliers. It sees demand for compact, energy-efficient devices that can operate in variable clinical conditions. Training initiatives and equipment leasing models are helping expand market reach in secondary care centers. Growth is also fueled by interest in dermatological and cosmetic treatments among affluent urban populations.

The Africa Phototherapy Equipment Market size was valued at USD 14.54 million in 2018 to USD 16.49 million in 2024 and is anticipated to reach USD 19.30 million by 2032, at a CAGR of 2.0% during the forecast period. Africa accounts for 2% of the global market and faces unique challenges related to infrastructure, access, and affordability. It shows potential for growth through targeted aid programs and healthcare development initiatives focusing on maternal and child health. The Phototherapy Equipment Market is slowly expanding, particularly in regions supported by international organizations and NGOs. It remains constrained by limited budgets, sporadic power supply, and a shortage of trained healthcare professionals. Countries such as South Africa, Kenya, and Nigeria are beginning to invest in low-cost, solar-powered, and portable devices. Strategic collaborations and localized manufacturing could enhance accessibility and improve neonatal outcomes across the continent.

Key Player Analysis:

• GE Healthcare
• Koninklijke Philips N.V.
• Natus Medical Incorporated
• Phoenix Medical Systems Pvt. Ltd.
• Herbert Waldmann GmbH & Co. KG
• Atom Medical Corporation
• Nice Neotech Medical Systems Pvt. Ltd.
• The Daavlin Company
• Solarc Systems, Inc.
• National Biological Corporation
• Other Key Players

Competitive Analysis:

The Phototherapy Equipment Market features a competitive landscape with the presence of both global and regional players focused on innovation, cost efficiency, and clinical efficacy. Key companies include GE HealthCare, Draeger, Natus Medical, Atom Medical, and Phoenix Medical Systems. These firms invest heavily in R&D to develop LED-based systems with smart monitoring, portability, and low energy consumption. The market is witnessing strategic partnerships, product launches, and geographic expansion to strengthen distribution networks and brand visibility. It remains highly dynamic, driven by technological upgrades and increasing demand across neonatal and dermatological care. Emerging players from Asia are gaining ground by offering affordable alternatives with localized manufacturing. Market leaders are differentiating through user-centric designs, service reliability, and regulatory compliance. The Phototherapy Equipment Market continues to evolve, with competition intensifying around features like multi-wavelength platforms, remote monitoring capabilities, and integration with telehealth services. Competitive positioning depends on innovation, pricing, and after-sales support.

Recent Developments:

• In March 2025, Dräger updated its neonatal care line with the introduction of the BiliLux™ Phototherapy Light, featuring LED-based phototherapy and BiliPredics software for precise bilirubin dosing in newborns. It supports guideline adherence and offers clinicians enhanced control over neonatal jaundice treatment.
• In April 2025, BioPhotas, Inc. launched the Celluma Series 2 DELUX, a full‑body LED device cleared by the FDA for four treatment modes-body contouring, wrinkle reduction, acne therapy, and pain relief. It combines multiple functions in one panel, offering durability, a digital timer, pause-and-resume functions, and comes in two sizes

Market Concentration & Characteristics:

The Phototherapy Equipment Market exhibits moderate market concentration, with a few established players dominating global revenues while regional firms address localized demand. It is characterized by continuous product innovation, strict regulatory oversight, and high clinical dependency, particularly in neonatal and dermatology care. The market prioritizes safety, energy efficiency, and treatment precision, leading to a focus on LED and hybrid device development. It also reflects a dual-channel structure, serving both hospital-based care and an expanding home-use segment. Barriers to entry include regulatory compliance, capital investment, and the need for clinical validation. The Phototherapy Equipment Market favors companies with strong R&D capabilities, global distribution, and scalable manufacturing.

Report Coverage:

The research report offers an in-depth analysis based on type, application, and end user. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook:

• Rising global birth rates will drive sustained demand for neonatal phototherapy units.
• Technological innovation will boost adoption of LED-based and multi-wavelength systems.
• Home-use phototherapy devices will gain traction in chronic skin condition management.
• Integration with telemedicine platforms will expand access to remote treatment.
• Increasing focus on cosmetic and aesthetic light therapies will open new revenue streams.
• Emerging markets will witness accelerated growth due to healthcare infrastructure expansion.
• Strategic partnerships and mergers will shape competitive dynamics and market reach.
• Portable and energy-efficient devices will cater to off-grid and rural healthcare needs.
• Regulatory support and inclusion in public health programs will enhance reimbursement access.
• AI-driven smart monitoring features will improve treatment outcomes and user compliance.

Rising Incidence of Neonatal Jaundice

A significant proportion of newborns globally, especially in developing countries, are affected by neonatal jaundice, necessitating immediate and effective phototherapy treatment. This drives hospitals and NICUs to invest in advanced phototherapy equipment to prevent severe complications.

Increasing Prevalence of Dermatological Disorders

The global rise in chronic skin conditions such as psoriasis, vitiligo, eczema, and acne is fueling demand for non-invasive, light-based therapies. Phototherapy offers effective, drug-free treatment options, leading to greater adoption in dermatology clinics and hospitals.

Technological Advancements in LED and Smart Devices

The shift from conventional fluorescent systems to LED-based phototherapy equipment has improved energy efficiency, device lifespan, and treatment outcomes. Integration of smart monitoring and AI-driven features further enhances safety, precision, and user convenience, accelerating market growth.

Expansion of Home-Based and Outpatient Care

Growing patient preference for home-based and outpatient phototherapy, supported by the availability of portable and user-friendly devices, is expanding the market beyond traditional hospital settings. This trend aligns with decentralized, patient-centric healthcare models.

Healthcare Infrastructure Growth in Emerging Markets

Rapid investments in healthcare infrastructure, public health initiatives, and increasing awareness in Asia Pacific, Latin America, and parts of Africa are expanding access to phototherapy equipment. These regions offer significant growth potential as neonatal and dermatological care services improve.

Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.